Godlike Productions - Conspiracy Forum
Users Online Now: 1,879 (Who's On?)Visitors Today: 668,356
Pageviews Today: 894,773Threads Today: 224Posts Today: 3,579
11:02 AM

Back to Forum
Back to Forum
Back to Thread
Back to Thread
Message Subject <<Advancing Bird Flu-H5N1...Now following MERS and Ebola approaching PANDEMICS>>>
Poster Handle arkay
Post Content
And just to highlight one very important reason why we might like to reconsider the contents of my previous post, we have this study done here in Australia on vaccination risks, and finding that risk increases could not be excluded for the small sampling used.

Its no wonder that the average age of nurses in my local hospital is 55 years old and that the government cant attract nurses to train nor can they even attract nursing staff from overseas.

Lousy pay, awfull working hours, overworked staff, the list goes on and now authorities would propose even more impediments.

Perhaps its these people making all these proposals that have too much free time on their hands and need to be directed to more productive tasks.

Med J Aust. 2012 Nov 19;197(10):574-8.
Guillain-Barré syndrome following pandemic (H1N1) 2009 influenza A immunisation in Victoria: a self-controlled case series.
Crawford NW, Cheng A, Andrews N, Charles PG, Clothier HJ, Day B, Day T, Gates P, Macdonnell R, Roberts L, Rodriguez-Casero V, Wijeratne T, Kiers L.
SourceRoyal Children's Hospital, Melbourne, VIC, Australia. nigel.crawford@rch.org.au.

OBJECTIVES: To determine the relative incidence (RI) of Guillain-Barré syndrome (GBS) in a single Australian state following pandemic (H1N1) 2009 influenza A immunisation (monovalent vaccine or seasonal trivalent influenza vaccine [TIV]) in 2009-2010.

DESIGN, SETTING AND PARTICIPANTS: Active GBS surveillance (cases assessed by two neurologists according to the Brighton criteria) from 30 September 2009 to 30 September 2010, conducted at 10 hospitals in Victoria, Australia.

MAIN OUTCOME MEASURES: The RI of GBS in the risk window of 0-42 days after vaccination.

RESULTS: Sixty-six potential GBS cases were identified, with complete data on 50 confirmed cases. The Victorian annual incidence of GBS was 1.7 per 100 000 population. Three cases had received monovalent vaccine and one case had received seasonal TIV within 42 days of symptom onset. The RI of GBS following monovalent vaccination was 3.4 (95% CI, 0.8-15.0). For TIV, there was one case in the risk period (RI, 0.69; 95% CI, 0.08-5.64).

CONCLUSIONS: This is the first published study reviewing GBS after a trivalent and/or monovalent influenza vaccine containing the pandemic (H1N1) 2009 strain, with only a small proportion of GBS cases occurring after influenza immunisation. H1N1-containing vaccines were not statistically associated with GBS, but this study could not exclude smaller increases in the RI. Active surveillance of adverse events following immunisation is required to maintain public and health care professional confidence in mass vaccine implementation programs.

Link here...

[link to www.ncbi.nlm.nih.gov]
Please verify you're human:

Reason for copyright violation: